Swiss Biotech MoonLake Picks Brickell Key for Its U.S. Headquarters, With Up to 75 Jobs

MIAMI — Brickell Key is better known for condo towers and a luxury hotel than for drug development. Soon it will also be the U.S. home of a Swiss-founded biotech company getting ready for a possible American product launch.

MoonLake Immunotherapeutics (Nasdaq: MLTX) plans to put its U.S. headquarters in Miami, with room for up to 75 employees, including some new local hires, the South Florida Business Journal reported on Nov. 6. The company is taking 13,500 square feet at Brickell Key Centre II, according to the Business Journal and a follow-up by South Florida Digest.

A Headquarters Built for a Launch

The Miami office is designed to support MoonLake’s U.S. commercial operations, including sales and marketing. Those are the teams a drug company builds when it expects to start selling a product.

That product would be sonelokimab, MoonLake’s lead drug candidate. The company describes it in its SEC filings as an investigational Nanobody, a type of small antibody fragment, being developed for hidradenitis suppurativa and other inflammatory conditions. Hidradenitis suppurativa is a chronic, painful skin disease.

In a Form 8-K filed Nov. 4, MoonLake said it submitted a Biologics License Application to the U.S. Food and Drug Administration on Sept. 30, seeking approval of sonelokimab for moderate-to-severe hidradenitis suppurativa, South Florida Digest reported. A submission is not an approval. The FDA still has to review the application, and the company hasn’t announced a launch date.

That’s the key thing to keep in mind about the 75 jobs. The figure is a ceiling, and the pace of hiring will likely depend on how the regulatory process goes. The public reports don’t give a hiring timetable, job titles, salaries or a breakdown of how many roles will be filled locally.

Why Brickell Key

Brickell Key Centre II is one of two office towers on the island, and the property lists the building at 226,300 square feet. MoonLake’s space will take up only a small part of it, but the choice is notable. Brickell Key sits just off the Brickell financial district, near the investors, banks and law firms that a public company works with, and close to Miami International Airport’s flights to Europe and Latin America.

For a company founded in Switzerland, those international connections matter. Miami’s pitch to foreign firms has long leaned on its role as a gateway between the U.S., Europe and Latin America, along with Florida’s lack of a state personal income tax.

Part of a Busy Week for Corporate Moves

MoonLake’s announcement came the same day the Business Journal reported that Sucden, a French commodities trading group, is moving its Latin America headquarters to Coral Gables. Sucden signed a 10-year lease at 255 Alhambra Circle and will relocate about 50 employees.

Just a week earlier, Nasdaq-listed AI infrastructure company Axe Compute said it was moving its headquarters from Pittsburgh to Brickell, with office space for about 30 people.

The three companies are very different in size and industry. Still, they all point the same way: international and public companies keep choosing Miami-Dade for headquarters and regional hubs, not just satellite offices.

A Small but Real Boost for Miami Life Sciences

Life sciences is still a small part of Miami’s economy compared with finance, real estate, tourism and trade. The region has research anchors like the University of Miami’s medical campus, but it has fewer commercial-stage drug companies than hubs such as Boston or San Diego.

A U.S. commercial headquarters doesn’t create a biotech cluster on its own. It does add something Miami has had less of: the commercial side of the industry, including sales leadership, market access, medical affairs and marketing roles. Those people tend to stay in a region and later join or start other companies.

What to Watch

For local founders, recruiters and service providers, here’s what to watch over the next year:

• The FDA review. A decision on sonelokimab will largely set the pace and size of MoonLake’s Miami hiring.
• Hiring. Watch for job postings for Miami-based commercial, marketing and operations roles.
• Vendors. A launch-stage biotech needs agencies, event planners, legal and compliance help, and office services. Local firms can compete for that work.
• Follow-on moves. One company choosing Miami for its U.S. commercial base could make it easier for other mid-sized international biotechs to do the same.

For now, the confirmed facts are a signed office commitment on Brickell Key and a plan to hire up to 75 people. Whether that grows into a larger Miami operation depends on what regulators decide next.